MindMaze Therapeutics Holding SA RLFTY Stock
MindMaze Therapeutics Holding SA Price Chart
MindMaze Therapeutics Holding SA RLFTY Financial and Trading Overview
| MindMaze Therapeutics Holding SA stock price | 0.42 USD |
| Previous Close | 0.3 USD |
| Open | 0.42 USD |
| Bid | 0.55 USD x 250000 |
| Ask | 1.7 USD x 78700 |
| Day's Range | 0.42 - 0.42 USD |
| 52 Week Range | 0.27 - 4.05 USD |
| Volume | 3.5K USD |
| Avg. Volume | 36 USD |
| Market Cap | 66.59M USD |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.61 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
RLFTY Valuation Measures
| Enterprise Value | N/A |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 0.12962104 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
MindMaze Therapeutics Holding SA Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | 15.51% |
| S&P500 52-Week Change | 27.29% |
| 52 Week High | 4.05 USD |
| 52 Week Low | 0.27 USD |
| 50-Day Moving Average | 1.68 USD |
| 200-Day Moving Average | 1.86 USD |
RLFTY Share Statistics
| Avg. Volume (3 month) | 36 USD |
| Avg. Daily Volume (10-Days) | 0 USD |
| Shares Outstanding | 157.6M |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | N/A |
| % Held by Institutions | N/A |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | N/A |
| Most Recent Quarter (mrq) | N/A |
| Next Fiscal Year End | N/A |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | N/A |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | N/A |
| Diluted EPS (ttm) | -0.61 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | N/A |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | N/A |
| Book Value Per Share (mrq) | 3.2595017 |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Profile of MindMaze Therapeutics Holding SA
| Country | United States |
| State | N/A |
| City | Geneva |
| Address | Avenue de Sécheron 15 |
| ZIP | 1202 |
| Phone | 41 21 552 08 01 |
| Website | https://mindmazetherapeutics.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
MindMaze Therapeutics Holding SA operates as a commercial-stage biopharmaceutical and neurotechnology company in Asia, the United States, Switzerland, rest of Europe, and internationally. The company offers MindPod system, a supervised in-clinic neurorehabilitation system designed to initiate and intensify the recovery journey; MindMotion GO, which extends protocolized neurotherapeutics into outpatient and home settings; MindMotion Companion, an application that manages prescription, monitoring and documentation across MindMaze Therapeutics' neurotherapeutics ecosystem; and the patient app, a patient-facing mobile application, that supports clinic-to-home continuity by making prescribed therapy easy to follow outside the clinic. It also provides Izar hand therapy device which supports fine motor rehabilitation; Physilog sensor, a wearable inertial sensing device designed to quantify human movement; toaprun, a training for Parkinson's therapy-reimagined through play. The company was founded in 2012 and is headquartered in Geneva, Switzerland.
Q&A For MindMaze Therapeutics Holding SA Stock
What is a current RLFTY stock price?
MindMaze Therapeutics Holding SA RLFTY stock price today per share is 0.42 USD.
How to purchase MindMaze Therapeutics Holding SA stock?
You can buy RLFTY shares on the OTC Markets OTCQB exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for MindMaze Therapeutics Holding SA?
The stock symbol or ticker of MindMaze Therapeutics Holding SA is RLFTY.
Which industry does the MindMaze Therapeutics Holding SA company belong to?
The MindMaze Therapeutics Holding SA industry is Biotechnology.
How many shares does MindMaze Therapeutics Holding SA have in circulation?
The max supply of MindMaze Therapeutics Holding SA shares is 157.6M.
What is MindMaze Therapeutics Holding SA Price to Earnings Ratio (PE Ratio)?
MindMaze Therapeutics Holding SA PE Ratio is now.
What was MindMaze Therapeutics Holding SA earnings per share over the trailing 12 months (TTM)?
MindMaze Therapeutics Holding SA EPS is -0.61 USD over the trailing 12 months.
Which sector does the MindMaze Therapeutics Holding SA company belong to?
The MindMaze Therapeutics Holding SA sector is Healthcare.